Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2003
07/10/2003US20030130507 Reacting (S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro -7H-pyrido(1,2,3-de) (1,4)benzoxazine-6-carboxylic acid with N-methyl piperazine at an elevated temperature to form levofloxacin; precipitation
07/10/2003US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects
07/10/2003US20030130335 Protein tyrosine phosphatases inhibitors
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130299 Administering dosage of immunology response moderator
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130272 Topoisomerase inhibitor; viricides
07/10/2003US20030130255 Pyridoquinoxaline antivirals
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130250 Methods to mobilize progenitor/stem cells
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/10/2003US20030130227 Uridine derivatives as antibiotics
07/10/2003US20030130226 Prevent reproduction of viruses; genetic engineering
07/10/2003US20030130225 Urogenital disorders; concurrent administering fluconazole by mouth and topical applying fungicide in situ
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130213 Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof
07/10/2003US20030130211 Injectable compositions for the controlled delivery of pharmacologically active compound
07/10/2003US20030130204 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
07/10/2003US20030130187 Porcine adenovirus type 3 genome
07/10/2003US20030130184 Using protein from papilloma virus; genetic engineering
07/10/2003US20030130173 Bactericides for drug resistant bacteria
07/10/2003US20030130171 Inhibitors of ABC drug transporters in multidrug resistant microbial cells
07/10/2003US20030130121 Novel bacterial isolate and the preparation and use of its active metabolites
07/10/2003US20030129744 Bvdv virus-like particles
07/10/2003US20030129733 Inactivated genomes of diploid microorganisms which are inducible into haploid forms; drug screening
07/10/2003US20030129728 Disrupting genes and mixing with plasmids/DNA vaccine; immunology; gene therapy; aging resistance
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129663 Methods and compositions for modulating oxidized ldl transport
07/10/2003US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase.
07/10/2003US20030129582 Method for determining early HCV seroconversion
07/10/2003US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier
07/10/2003US20030129203 Rep proteins; fusion proteins; high throughput assay; gene therapy
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129201 Methods of preventing and treating flavivirus infection in animals
07/10/2003US20030129199 Combined vaccine compositions
07/10/2003US20030129197 Influenza vaccine
07/10/2003US20030129196 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
07/10/2003US20030129195 Use of heat shock proteins
07/10/2003US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
07/10/2003US20030129181 Hydrolases modified by polyoxyethylene glycol for induction of high plasmatic levels of free tumor necrosis factor
07/10/2003US20030129172 Animal growth regulator
07/10/2003US20030129166 Human circulating dendritic cell compositions and methods
07/10/2003US20030129161 Interleukin-12 as a veterinary vaccine adjuvant
07/10/2003US20030129129 Prevention, therapy disease; forming tritiated water; calibration
07/10/2003CA2471916A1 Modified bacterial surface layer proteins
07/10/2003CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
07/10/2003CA2471679A1 Negatively charged polysaccharide derivable from aloe vera
07/10/2003CA2471348A1 Quinazolinone derivative
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471300A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2470903A1 A system for stable expression of sirnas in mammalian cells
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2470521A1 Anti-viral 7-deaza l-nucleosides
07/10/2003CA2463738A1 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/09/2003EP1325957A2 Recombinant papilloma virus L1
07/09/2003EP1325922A2 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
07/09/2003EP1325915A1 Monomeric and dimeric naphtylisoquinoline alkaloids and synthesis methods thereof
07/09/2003EP1325341A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins
07/09/2003EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin
07/09/2003EP1325134A2 Method to alter sugar moieties
07/09/2003EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325028A2 New inhibitors of iapp fibril formation and uses thereof
07/09/2003EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
07/09/2003EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
07/09/2003EP1324994A2 Tricyclic compounds and uses thereof
07/09/2003EP1324991A1 Compounds useful in the treatment of inflammatory diseases
07/09/2003EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
07/09/2003EP1324985A1 Inhibitors of prenyl-protein transferase
07/09/2003EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers
07/09/2003EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions
07/09/2003EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition
07/09/2003EP1324771A2 Therapeutic antibodies
07/09/2003EP1324769A2 Split enveloped virus preparation for intranasal delivery
07/09/2003EP1324768A2 Vaccines for proliferative ileitis
07/09/2003EP1324759A2 Nf-g(k)b inhibitors
07/09/2003EP1324748A1 Topical antibiotic composition for treatment of eye infection
07/09/2003EP1324736A2 Rapid antibiotic susceptibility test
07/09/2003EP1080109B1 Method for purification of borrelia lipoprotein ospa
07/09/2003EP1001778B1 Use of a rifamycin derivative for treating mastitis in a domestic animal
07/09/2003EP0973768B1 Azole compounds, their production and their use
07/09/2003EP0966465B1 Inhibitors of impdh enzyme
07/09/2003EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses
07/09/2003EP0937067B1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
07/09/2003EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
07/09/2003EP0741787B1 Mammalian expression systems for hepatitis c virus envelope genes
07/09/2003EP0716613B1 Treatment of helicobacter associated gastroduodenal disease
07/09/2003CN1429276A Modulating production of pneumococcal capsular polysaccharide
07/09/2003CN1429268A Novel deoxyribonucleside kinase enzyme multi-substrate variants
07/09/2003CN1429233A Method of preparing clarithromycin of form II crystals
07/09/2003CN1429232A Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals
1 ... 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 ... 1798